SCHEMBL18156789

SCHEMBL18156789

Brc1cccc2c1-c1ccccc1C21c2ccccc2-c2c1ccc1c2Cc2ccccc2-1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.41
PGR P06401 2/20 0.39
PNMT P11086 1/20 0.38
HTR7 P34969 2/20 0.35
HTR2B P41595 2/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DRD2 P14416 1/20 0.33
ADRA1D P25100 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156802 0.88 PDK2 (0.40) PDK2PGRPNMTHTR7HTR2B
SCHEMBL18156793 0.83 PDK2 (0.43) PDK2HTR2BNPC1RAB9AKDM4E
SCHEMBL4195471 0.80 PDK2 (0.58) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL29603205 0.80 PDK2 (0.58) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL18156797 0.80 PDK2 (0.40) PDK2PGRHTR7HTR2BNPC1
SCHEMBL18156799 0.80 PDK2 (0.40) PDK2PGRHTR7HTR2BNPC1
SCHEMBL29484645 0.78 PDK2 (0.56) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL16810678 0.78 PDK2 (0.56) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL10053123 0.78 PDK2 (0.56) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL18156791 0.78 PDK2 (0.41) PDK2HTR7HTR2BNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885PGR 1584/4885PNMT 2444/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885PGR 1584/4885PNMT 2444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.